Clinical Trial Update: Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports completion of a study evaluating cetuximab in combination with everolimus for patients with metastatic or recurrent colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)
• ERBITUX (cetuximab)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip | Phase 1 | Status: COMPLETED